Enriched with Disease-Relevant Antigens
Disease processes trigger cellular and protein changes long before symptoms arise. The immune system, constantly vigilant, detects these changes and marks them with antibodies. Profiling these antibodies is crucial for identifying targetable and exploitable biomarkers: pathogenic antibodies, protective antibodies, and protein antigens.
Our advanced microarrays are enriched with protein antigens involved in critical biological processes such as signaling, metabolism, gene expression, growth, and apoptosis—processes central to nearly all diseases. This targeted approach ensures the discovery of the most relevant biomarkers for early detection and treatment strategies.
